KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Profit After Tax: 2009-2025

Historic Profit After Tax for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to $274.6 million.

  • Idexx Laboratories' Profit After Tax rose 17.94% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.61%. This contributed to the annual value of $887.9 million for FY2024, which is 5.07% up from last year.
  • As of Q3 2025, Idexx Laboratories' Profit After Tax stood at $274.6 million, which was down 6.59% from $294.0 million recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Profit After Tax peaked at $294.0 million during Q2 2025, and registered a low of $132.0 million during Q2 2022.
  • For the 3-year period, Idexx Laboratories' Profit After Tax averaged around $231.3 million, with its median value being $224.2 million (2023).
  • In the last 5 years, Idexx Laboratories' Profit After Tax skyrocketed by 82.64% in 2021 and then plummeted by 34.86% in 2022.
  • Idexx Laboratories' Profit After Tax (Quarterly) stood at $162.8 million in 2021, then climbed by 5.80% to $172.2 million in 2022, then grew by 12.96% to $194.5 million in 2023, then increased by 11.12% to $216.1 million in 2024, then increased by 17.94% to $274.6 million in 2025.
  • Its Profit After Tax was $274.6 million in Q3 2025, compared to $294.0 million in Q2 2025 and $242.7 million in Q1 2025.